Impact of Janus Kinase Inhibitors on Antibody Response to 13-Valent Pneumococcal Conjugate Vaccine in Patients with Rheumatoid Arthritis.

Shunsuke MoriYukitaka UekiNaruhiko Ishiwada

Published in: Modern rheumatology (2022)

Although JAKIs do not impair PCV13 immunogenicity in RA patients, the combination of MTX with JAKI can reduce the antibody response in this patient population.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
rheumatoid arthritis
prognostic factors
case report
disease activity
ankylosing spondylitis
systemic sclerosis